Nexalis Therapeutics is committed to maintaining high standards of corporate governance and transparency in accordance with ASX Listing Rules and the ASX Corporate Governance Principles and Recommendations.
Corporate Governance Statement 2024
Our annual statement of compliance with the ASX Corporate Governance Principles and Recommendations (4th Edition).
Download PDFGovernance Framework
Access our comprehensive governance documents that ensure accountability, transparency, and ethical conduct across all operations.
Committee Charters
Board & committee governance
Board Charter
Role, responsibilities, and composition of the Board of Directors.
Audit & Risk Committee Charter
Oversight of financial reporting, audit, and risk management.
Nomination & Remuneration Policy
Committee charter governing executive remuneration policies.
Risk Management Policy
Framework for identifying and managing business risks.
Policies & Standards
Corporate conduct guidelines
Code of Conduct
Ethical standards for directors, officers, and employees.
Securities Trading Policy
Guidelines for trading in company securities.
Communication & Disclosure Policy
ASX continuous disclosure and shareholder communication.
Whistleblower Policy
Protection for reporting misconduct and unethical behavior.
Anti-Bribery & Corruption Policy
Standards for preventing bribery and corrupt conduct.
Diversity Policy
Commitment to workplace diversity and inclusion.
ASX Corporate Governance Principles
The Company has adopted the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations (4th Edition). Details of the Company's compliance with these principles are outlined in our Corporate Governance Statement, which is released annually with our Annual Report.
Visit ASX Corporate Governance Council